Study to evaluate the effect of continuous intake of test food on cognitive function

Study to evaluate the effect of continuous intake of test food on cognitive function - Study to evaluate the effect of continuous intake of test food on cognitive function

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000042995

Enrollment

Registered

2021-01-25

Start date

2021-01-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Take 3 tablets of test food after breakfast daily Take 3 tablets of placebo after breakfast daily

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Age between 20 and 64 years at the time of informed consent. 2. Japanese male or female. 3. Participants who are aware of forgetfulness or have been pointed out by others about forgetfulness. 4. Participants who are able to input electronic diary with smartphone / PC. 5. Those who received sufficient explanation about the trial, volunteered to participate after understanding the purpose, and agree to participate in the trial with written consent.

Exclusion criteria

Exclusion criteria: 1. taking medication or Chinese medication (except for the drugs as needed) 2. on diet / exercise therapy under the guidance of a doctor 3. strabismus 4. current or history of serious diseases such as liver, kidney, heart, respiratory, endocrine and metabolic diseases. 5. current or history of mental disorders (including depressive symptoms) or cerebrovascular disease 6. experience of taking a neuropsychological test at a hospital etc. 7. MMSE score of =<23 8. taking healthy food or supplements daily (subjects who can stop taking those after providing consent are acceptable) 9. current or history of allergy for some drugs or food (possible allergy for test food) 10. participation in another clinical trial within one month of enrollment into the trial, participating currently or planning to participate 11. pregnant or lactating, or willing to be pregnant during the trial 12. alcohol consumption of >60g equivalent 13. smoker 14. working in shift or late at night, irregular life rhythms 15. judged by the investigator to be unsuitable for participating in this study

Design outcomes

Primary

Measure	Time frame
MMSE	—

Secondary

Measure	Time frame
Visual cognitive function test Subjective symptom questionnaire	—

Countries

Japan

Contacts

Public ContactHirokuni Kayama

IMEQRD Co., Ltd Planning and Sales Department

clinical-trial@imeqrd.co.jp03-6704-5968

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026